<p>PetMed Express, Inc.（納斯達克代碼：PETS - 獲取免費報告）在 12 月份的空頭頭寸大幅增加。截至 12 月 15 日，空頭頭寸總計為 2,698,921 股，比 11 月 30 日的 1,604,421 股增加了 68.2%。根據平均每日交易量 12,363,353 股，目前的空頭頭寸比率為 0.2 天。大約 12.9% 的股票被做空。</p>
<p>獲取 <strong>PetMed Express</strong> 警報：</p>
<h2>PetMed Express 股價下跌 2.3%</h2>
<ul>
<li>Petco Health &amp; Wellness 是否因每股收益超預期而擺脱困境？</li>
</ul>
<p>在週五的交易時段，PetMed Express 股票下跌了 0.08 美元，報 3.47 美元。該公司交易了 108,088 股，較其平均交易量 7,696,855 股有所減少。該股票的市值為 7415 萬美元，市盈率為-1.31，貝塔值為 0.75。該公司的 50 日移動平均線為 2.46 美元，200 日移動平均線為 2.86 美元。PetMed Express 的 1 年最低價為 1.57 美元，1 年最高價為 5.58 美元。</p>
<p>PetMed Express（納斯達克代碼：PETS - 獲取免費報告）最後一次公佈季度財報是在 12 月 19 日（星期五）。該公司報告季度每股收益為（0.41 美元），低於市場共識預期的 0.04 美元，差距為（0.45 美元）。PetMed Express 的淨利潤率為-28.22%，股本回報率為-40.26%。該公司在本季度的收入為 4436 萬美元。整體來看，研究分析師預計 PetMed Express 在當前財年將發佈 0.19 美元的每股收益。</p>
<h2>機構投資者對 PetMed Express 的看法</h2>
<ul>
<li>這裏有一隻不在困境中的寵物股票</li>
</ul>
<p>幾家對沖基金最近對該公司的持倉進行了調整。R Squared Ltd 在第二季度新建了約 34,000 美元的 PetMed Express 持倉。Occudo Quantitative Strategies LP 在第二季度以 51,000 美元的價格收購了 PetMed Express 的新股份。Oxford Asset Management LLP 在第二季度以 55,000 美元的價格收購了 PetMed Express 的新股份。CIBC Private Wealth Group LLC 在第三季度以 75,000 美元的價格購買了 PetMed Express 的新股份。最後，Bridgeway Capital Management LLC 在第二季度將其在 PetMed Express 的持股增加了 96.2%。Bridgeway Capital Management LLC 目前擁有 40,800 股該公司的股票，價值 135,000 美元，此前在上個季度又購買了 20,000 股。機構投資者和對沖基金持有該公司 73.33% 的股份。</p>
<h2>分析師評級變動</h2>
<p>幾位分析師最近對 PETS 股票發佈了報告。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 PetMed Express 股票的 “賣出（d）” 評級。Zacks Research 在 9 月 29 日的研究報告中將 PetMed Express 的評級從 “強烈賣出” 上調至 “持有”。最後，Wall Street Zen 在 10 月 18 日的研究報告中將 PetMed Express 的評級從 “持有” 下調至 “賣出”。一位研究分析師對該股票給予了 “持有” 評級，另外兩位分析師給予了 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “賣出”，平均目標價為 3.20 美元。</p>
<ul>
<li>這五隻寵物護理股票中的一隻可能成為下一個空頭擠壓</li>
</ul>
<p><strong>獲取我們關於 PetMed Express 的最新研究報告</strong></p>
<h2>關於 PetMed Express</h2>
<p>（獲取免費報告）</p>
<p>PetMed Express, Inc.以 1-800-PetMeds 品牌名義運營，作為一家在線和目錄基礎的寵物藥房和零售供應商。該公司直接向消費者分發處方和非處方藥物、營養補充劑、跳蚤和蜱蟲控制產品以及一系列寵物健康用品。通過其位於佛羅里達州德爾雷海灘的持牌獸醫藥房，PetMed Express 為狗、貓和其他伴侶動物處理訂單，提供品牌和仿製產品以及自有品牌的配方。</p>
<p>PetMed Express 於 1996 年由 Marc Puleo 創立，基於為尋求可靠獸醫藥物的寵物主人提供便利和節省成本的理念建立了其業務。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過 PetMed Express</li>
<li>華爾街選股者評選 2026 年第一股票</li>
<li>“6.6 萬億美元的客户銀行存款面臨風險”</li>
<li>華盛頓為戰爭做準備</li>
<li>崩盤前一個月</li>
<li>麥當勞的秘密</li>
</ul>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 PetMed Express 嗎？</h2>
<p>在你考慮 PetMed Express 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 PetMed Express 並不在名單上。</p>
<p>雖然 PetMed Express 目前在分析師中被評為 “賣出”，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

PETS

<p>PetMed Express, Inc.（納斯達克代碼：PETS）在 12 月份的空頭頭寸顯著增加了 68.2%，總計達到 2,698,921 股。該公司約有 12.9% 的股票被賣空，覆蓋天數比率為 0.2 天。該股票最近下跌了 2.3%，市值為 7415 萬美元。分析師對該股票的共識評級為 “賣出”，機構投資者持有 73.33% 的股份。公司報告上個季度的每股收益為負值（$0.41），低於預期$0.45</p>

<p>PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 2,698,921 shares, an increase of 68.2% from the November 30th total of 1,604,421 shares. Based on an average daily trading volume, of 12,363,353 shares, the short-interest ratio is presently 0.2 days. Approximately 12.9% of the shares of the stock are short sold. Approximately 12.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 12,363,353 shares, the short-interest ratio is presently 0.2 days.</p>
<div class="lb-trans"><p>PetMed Express, Inc.（納斯達克代碼：PETS - 獲取免費報告）在 12 月份的空頭頭寸大幅增加。截至 12 月 15 日，空頭頭寸總計為 2,698,921 股，比 11 月 30 日的 1,604,421 股增加了 68.2%。根據平均每日交易量 12,363,353 股，目前的空頭頭寸比率為 0.2 天。大約 12.9% 的股票被做空。</p>
</div><p>Get <strong>PetMed Express</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>PetMed Express</strong> 警報：</p>
</div><h2>PetMed Express Trading Down 2.3%</h2>
<div class="lb-trans"><h2>PetMed Express 股價下跌 2.3%</h2>
</div><ul>
<li>Is Petco Health &amp; Wellness Out of the Doghouse on an EPS beat?</li>
</ul>
<div class="lb-trans"><ul>
<li>Petco Health &amp; Wellness 是否因每股收益超預期而擺脱困境？</li>
</ul>
</div><p>Shares of PetMed Express stock traded down $0.08 during trading hours on Friday, hitting $3.47. 108,088 shares of the company were exchanged, compared to its average volume of 7,696,855. The stock has a market capitalization of $74.15 million, a price-to-earnings ratio of -1.31 and a beta of 0.75. The business has a 50-day moving average of $2.46 and a 200-day moving average of $2.86. PetMed Express has a 1 year low of $1.57 and a 1 year high of $5.58.</p>
<div class="lb-trans"><p>在週五的交易時段，PetMed Express 股票下跌了 0.08 美元，報 3.47 美元。該公司交易了 108,088 股，較其平均交易量 7,696,855 股有所減少。該股票的市值為 7415 萬美元，市盈率為-1.31，貝塔值為 0.75。該公司的 50 日移動平均線為 2.46 美元，200 日移動平均線為 2.86 美元。PetMed Express 的 1 年最低價為 1.57 美元，1 年最高價為 5.58 美元。</p>
</div><p>PetMed Express (NASDAQ:PETS - Get Free Report) last announced its quarterly earnings data on Friday, December 19th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.45). PetMed Express had a negative net margin of 28.22% and a negative return on equity of 40.26%. The company had revenue of $44.36 million during the quarter. As a group, research analysts anticipate that PetMed Express will post 0.19 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>PetMed Express（納斯達克代碼：PETS - 獲取免費報告）最後一次公佈季度財報是在 12 月 19 日（星期五）。該公司報告季度每股收益為（0.41 美元），低於市場共識預期的 0.04 美元，差距為（0.45 美元）。PetMed Express 的淨利潤率為-28.22%，股本回報率為-40.26%。該公司在本季度的收入為 4436 萬美元。整體來看，研究分析師預計 PetMed Express 在當前財年將發佈 0.19 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On PetMed Express</h2>
<div class="lb-trans"><h2>機構投資者對 PetMed Express 的看法</h2>
</div><ul>
<li>Here’s The One Pet Stock That’s Not in the Doghouse</li>
</ul>
<div class="lb-trans"><ul>
<li>這裏有一隻不在困境中的寵物股票</li>
</ul>
</div><p>Several hedge funds have recently made changes to their positions in the business. R Squared Ltd acquired a new position in PetMed Express during the 2nd quarter worth approximately $34,000. Occudo Quantitative Strategies LP acquired a new stake in PetMed Express during the 2nd quarter valued at $51,000. Oxford Asset Management LLP acquired a new stake in PetMed Express during the 2nd quarter valued at $55,000. CIBC Private Wealth Group LLC purchased a new stake in PetMed Express during the 3rd quarter worth $75,000. Finally, Bridgeway Capital Management LLC lifted its holdings in PetMed Express by 96.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company's stock worth $135,000 after buying an additional 20,000 shares in the last quarter. Institutional investors and hedge funds own 73.33% of the company's stock.</p>
<div class="lb-trans"><p>幾家對沖基金最近對該公司的持倉進行了調整。R Squared Ltd 在第二季度新建了約 34,000 美元的 PetMed Express 持倉。Occudo Quantitative Strategies LP 在第二季度以 51,000 美元的價格收購了 PetMed Express 的新股份。Oxford Asset Management LLP 在第二季度以 55,000 美元的價格收購了 PetMed Express 的新股份。CIBC Private Wealth Group LLC 在第三季度以 75,000 美元的價格購買了 PetMed Express 的新股份。最後，Bridgeway Capital Management LLC 在第二季度將其在 PetMed Express 的持股增加了 96.2%。Bridgeway Capital Management LLC 目前擁有 40,800 股該公司的股票，價值 135,000 美元，此前在上個季度又購買了 20,000 股。機構投資者和對沖基金持有該公司 73.33% 的股份。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>Several analysts have recently issued reports on PETS shares. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of PetMed Express in a research report on Wednesday, October 8th. Zacks Research upgraded PetMed Express from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 29th. Finally, Wall Street Zen downgraded PetMed Express from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research report on Saturday, October 18th. One research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Sell&#34; and an average price target of $3.20.</p>
<div class="lb-trans"><p>幾位分析師最近對 PETS 股票發佈了報告。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 PetMed Express 股票的 “賣出（d）” 評級。Zacks Research 在 9 月 29 日的研究報告中將 PetMed Express 的評級從 “強烈賣出” 上調至 “持有”。最後，Wall Street Zen 在 10 月 18 日的研究報告中將 PetMed Express 的評級從 “持有” 下調至 “賣出”。一位研究分析師對該股票給予了 “持有” 評級，另外兩位分析師給予了 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “賣出”，平均目標價為 3.20 美元。</p>
</div><ul>
<li>One of these 5 Pet Care Stocks Can Be the Next Short Squeeze</li>
</ul>
<div class="lb-trans"><ul>
<li>這五隻寵物護理股票中的一隻可能成為下一個空頭擠壓</li>
</ul>
</div><p><strong>Get Our Latest Research Report on PetMed Express</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 PetMed Express 的最新研究報告</strong></p>
</div><h2>About PetMed Express</h2>
<div class="lb-trans"><h2>關於 PetMed Express</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.</p>
<div class="lb-trans"><p>PetMed Express, Inc.以 1-800-PetMeds 品牌名義運營，作為一家在線和目錄基礎的寵物藥房和零售供應商。該公司直接向消費者分發處方和非處方藥物、營養補充劑、跳蚤和蜱蟲控制產品以及一系列寵物健康用品。通過其位於佛羅里達州德爾雷海灘的持牌獸醫藥房，PetMed Express 為狗、貓和其他伴侶動物處理訂單，提供品牌和仿製產品以及自有品牌的配方。</p>
</div><p>Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.</p>
<div class="lb-trans"><p>PetMed Express 於 1996 年由 Marc Puleo 創立，基於為尋求可靠獸醫藥物的寵物主人提供便利和節省成本的理念建立了其業務。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than PetMed Express</li>
<li>Wall Street Stockpicker Names #1 Stock of 2026</li>
<li>“$6.6 Trillion Of Customer Bank Deposits At Risk”</li>
<li>Washington prepares for war</li>
<li>A month before the crash</li>
<li>The McDonald's Secret</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 PetMed Express</li>
<li>華爾街選股者評選 2026 年第一股票</li>
<li>“6.6 萬億美元的客户銀行存款面臨風險”</li>
<li>華盛頓為戰爭做準備</li>
<li>崩盤前一個月</li>
<li>麥當勞的秘密</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in PetMed Express Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 PetMed Express 嗎？</h2>
</div><p>Before you consider PetMed Express, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 PetMed Express 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 PetMed Express 並不在名單上。</p>
</div><p>While PetMed Express currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 PetMed Express 目前在分析師中被評為 “賣出”，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

PetMed Express, Inc. (NASDAQ:PETS) 的空頭頭寸更新